Xarelto Lawsuit From New Jersey Joins MDL 2592

July 04, 2016 – – TheProductLawyers.com reports on the latest lawsuit against Janssen Pharmaceuticals and Bayer AG focused on their new-generation drug, Xarelto. The plaintiff, a New Jersey man, claims that the pharmaceutical companies were negligent in their duty to warn both the public and medical professionals of the dangerous complications and side effects associated with the use of the drug. He says that after six months of using Xarelto, he suffered from a massive gastrointestinal bleed, which will require ongoing treatment.

His case, filed in the federal court of the Eastern District of Louisiana in November of 2015, will join the more than 2,800 court cases that cite similar grievances. In December of 2015, after receiving a petition for consolidation, the U.S. Judicial Panel on Multidistrict Litigation (JPML) issued an order to create multidistrict litigation (MDL) 2592.

All lawsuits against the aforementioned drug companies that cite the common allegations of negligence and potential harm in connection with Xarelto will be combined, including any subsequent federal court cases that arise. Both MDL 2592 and a mass tort program of more than 550 cases—which is slated to appear before the Philadelphia Court of Common Pleas—assert that the drug posed a serious risk of injury and that the drug companies failed to warn patients or doctors adequately.

“Our lawsuits allege that the manufacturers failed to warn our clients about the severe side effects that our client’s suffered from, while taking the drug”, said attorney Laurence Banville, a contributor to the Xarelto litigation updates on TheProductLawyers.com. “We are speaking with families who have had brain bleeds, gastrointestinal bleeds, vaginal bleeding, and bleeding from trauma where hospitalization and extreme measures were taken by medical staff to help save the patient’s life,” Banville continued. “We look forward to fighting for the rights of our clients and pursuing just compensation for the injuries and hospitalization.” For more information about the side effects and how to pursue legal action, you can contact Banville Law at 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60011169